These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 23870052)

  • 21. Leptin-leptin receptor are involved in angiogenesis in human hepatocellular carcinoma.
    Ribatti D; Belloni AS; Nico B; Di Comite M; Crivellato E; Vacca A
    Peptides; 2008 Sep; 29(9):1596-602. PubMed ID: 18573568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma.
    Yang XR; Xu Y; Yu B; Zhou J; Qiu SJ; Shi GM; Zhang BH; Wu WZ; Shi YH; Wu B; Yang GH; Ji Y; Fan J
    Gut; 2010 Jul; 59(7):953-62. PubMed ID: 20442200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver.
    El-Assal ON; Yamanoi A; Soda Y; Yamaguchi M; Igarashi M; Yamamoto A; Nabika T; Nagasue N
    Hepatology; 1998 Jun; 27(6):1554-62. PubMed ID: 9620326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sorafenib down-regulates expression of HTATIP2 to promote invasiveness and metastasis of orthotopic hepatocellular carcinoma tumors in mice.
    Zhang W; Sun HC; Wang WQ; Zhang QB; Zhuang PY; Xiong YQ; Zhu XD; Xu HX; Kong LQ; Wu WZ; Wang L; Song TQ; Li Q; Tang ZY
    Gastroenterology; 2012 Dec; 143(6):1641-1649.e5. PubMed ID: 22922424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adaptor protein sorting nexin 17 interacts with the scavenger receptor FEEL-1/stabilin-1 and modulates its expression on the cell surface.
    Adachi H; Tsujimoto M
    Biochim Biophys Acta; 2010 May; 1803(5):553-63. PubMed ID: 20226821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclooxygenase-2 pathway correlates with vascular endothelial growth factor expression and tumor angiogenesis in hepatitis B virus-associated hepatocellular carcinoma.
    Cheng AS; Chan HL; To KF; Leung WK; Chan KK; Liew CT; Sung JJ
    Int J Oncol; 2004 Apr; 24(4):853-60. PubMed ID: 15010822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis.
    Llovet JM; Chen Y; Wurmbach E; Roayaie S; Fiel MI; Schwartz M; Thung SN; Khitrov G; Zhang W; Villanueva A; Battiston C; Mazzaferro V; Bruix J; Waxman S; Friedman SL
    Gastroenterology; 2006 Dec; 131(6):1758-67. PubMed ID: 17087938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ESM-1 silencing decreased cell survival, migration, and invasion and modulated cell cycle progression in hepatocellular carcinoma.
    Kang YH; Ji NY; Lee CI; Lee HG; Kim JW; Yeom YI; Kim DG; Yoon SK; Kim JW; Park PJ; Song EY
    Amino Acids; 2011 Mar; 40(3):1003-13. PubMed ID: 20821239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LIM and SH3 protein 1, a promoter of cell proliferation and migration, is a novel independent prognostic indicator in hepatocellular carcinoma.
    Wang H; Li W; Jin X; Cui S; Zhao L
    Eur J Cancer; 2013 Mar; 49(4):974-83. PubMed ID: 23084841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PLOD2 induced under hypoxia is a novel prognostic factor for hepatocellular carcinoma after curative resection.
    Noda T; Yamamoto H; Takemasa I; Yamada D; Uemura M; Wada H; Kobayashi S; Marubashi S; Eguchi H; Tanemura M; Umeshita K; Doki Y; Mori M; Nagano H
    Liver Int; 2012 Jan; 32(1):110-8. PubMed ID: 22098155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of Id proteins in human hepatocellular carcinoma: relevance to tumor dedifferentiation.
    Damdinsuren B; Nagano H; Kondo M; Yamamoto H; Hiraoka N; Yamamoto T; Marubashi S; Miyamoto A; Umeshita K; Dono K; Nakamori S; Wakasa K; Sakon M; Monden M
    Int J Oncol; 2005 Feb; 26(2):319-27. PubMed ID: 15645115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
    Tátrai P
    Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular changes in hepatocellular carcinoma.
    Yang ZF; Poon RT
    Anat Rec (Hoboken); 2008 Jun; 291(6):721-34. PubMed ID: 18484619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Caveolin-1 overexpression is associated with hepatocellular carcinoma tumourigenesis and metastasis.
    Tse EY; Ko FC; Tung EK; Chan LK; Lee TK; Ngan ES; Man K; Wong AS; Ng IO; Yam JW
    J Pathol; 2012 Mar; 226(4):645-53. PubMed ID: 22072235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The molecular mechanism underlying angiogenesis in hepatocellular carcinoma: the imbalance activation of signaling pathways.
    Zhao ZC; Zheng SS; Wan YL; Jia CK; Xie HY
    Hepatobiliary Pancreat Dis Int; 2003 Nov; 2(4):529-36. PubMed ID: 14627514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
    Dong-Dong L; Xi-Ran Z
    Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. siRNA targeting VEGF inhibits hepatocellular carcinoma growth and tumor angiogenesis in vivo.
    Raskopf E; Vogt A; Sauerbruch T; Schmitz V
    J Hepatol; 2008 Dec; 49(6):977-84. PubMed ID: 18845354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Common lymphatic endothelial and vascular endothelial receptor-1 mediates the transmigration of regulatory T cells across human hepatic sinusoidal endothelium.
    Shetty S; Weston CJ; Oo YH; Westerlund N; Stamataki Z; Youster J; Hubscher SG; Salmi M; Jalkanen S; Lalor PF; Adams DH
    J Immunol; 2011 Apr; 186(7):4147-55. PubMed ID: 21368224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Podocalyxin-like protein 1 expression in primary hepatic tumours and tumour-like lesions.
    Heukamp LC; Fischer HP; Schirmacher P; Chen X; Breuhahn K; Nicolay C; Büttner R; Gütgemann I
    Histopathology; 2006 Sep; 49(3):242-7. PubMed ID: 16918970
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Expression of ESM-1 in hepatocellular carcinoma is associated with angiogenesis and tumor invasion].
    Xiang X; Zhao WB; Wang X
    Zhonghua Gan Zang Bing Za Zhi; 2009 Sep; 17(9):661-4. PubMed ID: 19785952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.